Skip to main content
. 2013 Aug 28;37(11):2109–2118. doi: 10.1007/s00264-013-2053-8

Table 3.

Detailed summary of included studies

Trials and year No. of hips (D/N) No. of patients, D/N Mean or mean (SD), D/N
Infection Reoperation Blood transfusion DVT PE Wound haematomas Limb swelling Reinforcement Oozing Total blood loss (mL) Blood transfusion (U) Pain (VAS)
Beer, 1991 12/12 0/0 0/0 0/0 NSD NSD
Murphy, 1993 20/20 1/0 1455/1134
Ritter, 1994 78/62 0/0 15/13 0/0 0/0 0/0 0.59/0.47
O’Brien, 1997 440/432 1/2 0/1 NSD NSD 48/45 1431/784.76
Ovadia, 1997 18/12 0/0 9/2 1/0 2/2 1.44/1.5
Crevoisier, 1998 33/33 0/0 2/0 NSD 2/2
Kim, 1998 48/48 0/0 0/0 35/44 NSD
Niskanen, 2000 27/31 1/1 0/0 0/0 0/0 9/21 1/2 588/612 1.8/1.8
Ravikumar, 2001 12-/13 1/7 1/3 2/2
Widman, 2002 10-/12 1/1 9/6 NSD 4.12(2.9)/1.18(0.92)
Hill, 2003 NA 39/45 NSD
Gonzalez DV, 2004 53/51 2/0 1/0 21/18 1/1 1/0 2/0 NSD 6/10 1.6/1.5
Johansson, 2005 54/51 3/2 36/28 3/0 0/0 1695(712)/1510( 656) 2(2)/1.4(1.5)
Walmsley, 2005 282/295 19/23 1/2 3/1 2/1 0/1
Matsuda, 2006 20/20 0/0 0/0 0/0 0/0 2/6 0/0 NSD
Dora, 2007 50/50 0/0 1/0 1/1 NSD 2346(1034)/2195(1110) 2.4(1.6)/2.5(1.9) 1.9(1.5)/1.8(1.6) (Day 2),
1.8(1.6)/2.0(1.5)(Day 6)
Strahovnik, 2010 46/42(24H) 51/42(48H) 1/0 1/0 0/0 0/0 4/20 959/1098(24H); 1052/1098(48H) 2.33/3.235(24H), 3.175/3.235(48H)
Cheung, 2010 52/48 2/0 0/0 19/6 1a 1.89/1.83
Kleinert, 2012 40/40 0/0 0/1 4/4 NSD 1.4(1.9)/2.1(1.7)(Day 1),
1(1.5)/1.4(2.3)(Day 2),
0.7(1.2)/0.7(1.2)(Day 3)
Roth, 2012 40/40 0/0 NSD 900/900 0/0 2/1.2(Day1,Rest),
3.8/2.7(Day 1, Stress),
0.6/0.3(Day 4, Rest)
2.2/1.4(Day 4, Stress)

D drainage, ND no drainage, H hour, NSD no significant difference and without detailed data, DVT deep vein thrombosis, PE pulmonary embolism, U unit, VAS visual analogue scale

a One patient had PE without specific group.